|
?:reviewBody
|
-
On December 8, Corporación Venezolana de Televisión (VTV), Venezuela’s government official television station, reported that CoronaVac, China’s COVID-19 vaccine, showed 97 percent efficacy, meaning that in human testing, the vaccination resulted in 97 percent fewer cases than would be expected with no vaccination. That statistic came from Indonesia's state pharmaceutical company Bio Farma, a partner of the Chinese vaccine maker Sinovac Biotech, based on early clinical trials. However, that same day, Bloomberg News reported that Sinovac had denied the 97 percent efficacy claim. Sinovac’s spokesperson told Bloomberg News that the vaccine’s shot created antibodies among 97% of those administered with it in a final stage trial in Indonesia
(en)
|
![[This page as RDF]](http://data.gesis.org/claimskg/static/rdf-icon.gif){kind=icon}